Long-Term Survival in a Large Cohort of Patients with Venous Thrombosis: Incidence and Predictors

Linda Flinterman and colleagues report on the long-term mortality rate for individuals who have experienced a first venous thrombosis or pulmonary embolism. They describe an ongoing elevated risk of death for individuals who had experienced a venous thrombosis or pulmonary embolism as compared to controls, for up to eight years after the event.

• Publication year

  2012

• Venue

  PLoS Medicine

• Publication date

  2012-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1371/journal.pmed.1001155PMID 22253578PMCID 3254666
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical Centers

  2013cited by this paper
• Long-term survival of patients with a history of venous thromboembolism

  2010cited by this paper
• Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism: Findings From the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry

  2009cited by this paper
• Venous and arterial thrombosis: different sides of the same coin?

  2008cited by this paper
• Gene variants associated with deep vein thrombosis.

  2008cited by this paper
• Incidence and mortality of venous thrombosis: a population‐based study

  2007cited by this paper
• The Impact of Venous Thromboembolism on Risk of Death or Hemorrhage in Older Cancer Patients

  2007cited by this paper
• Links between arterial and venous disease

  2007cited by this paper
• Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism

  2006cited by this paper
• The Post-thrombotic Syndrome: The Forgotten Morbidity of Deep Venous Thrombosis

  2006cited by this paper
• The risk of recurrent venous thromboembolism in men and women.

  2004cited by this paper
• Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study.

  2003cited by this paper
• Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study.

  2000cited by this paper
• Prognosis of cancers associated with venous thromboembolism.

  2000influential reference
• Incidence of Venous Thromboembolism: A Community-based Study in Western France

  2000cited by this paper
• Venous thrombosis: a multicausal disease.

  1999cited by this paper
• Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study.

  1999cited by this paper
• Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)

  1999cited by this paper
• Long-term outcomes of deep-vein thrombosis.

  1995cited by this paper

• Effect of Body Mass Index in Perioperative Outcomes on Free-Flap Breast Reconstruction Surgery

  2026cites this paper
• Cost Effectiveness of Mechanical Thrombectomy versus Anticoagulation for Treating Iliofemoral Deep Vein Thrombosis in the UK.

  2025cites this paper
• A Systemic Review and Meta‐Analysis of the Risk of Venous Thromboembolic Events in Parkinson's Patients

  2025cites this paper
• Cancer-associated venous thromboembolism and its impact on survival in the ONCOTHROMB12-01 cohort study

  2025cites this paper
• Effects on mortality of extended versus short-term anticoagulation in venous thromboembolism: a systematic review and meta-analysis of randomized trials

  2025cites this paper
• The association between the polymorphism of FXI c.539A>G and venous thromboembolism in the population of central china.

  2025cites this paper
• When is it time to bid farewell to anticoagulation?

  2025cites this paper
• Unveiling dynamics of nitrogen content and selected nitrogen heterocycles in thrombin inhibitors: a ceteris paribus approach

  2024cites this paper
• The adapted Caprini score as a proxy forpostoperative venous thromboembolismprophylaxis: a tertiary hospital experience.

  2024cites this paper
• Gender-specific relationships between hyperuricemia and idiopathic deep venous thrombosis in the Chinese population: a case‒control study

  2024cites this paper
• Harnessing Artificial Neural Networks for Spinal Cord Injury Prognosis

  2024cites this paper
• In-Hospital versus Out-of-Hospital Pulmonary Embolism: Clinical Characteristics, Biochemical Markers and Echocardiographic Indices

  2024cites this paper
• Long-term mortality in patients with pulmonary embolism: results in a single-center registry

  2023influential citation
• Risk Factors for Bleeding in Cancer Patients Treated with Conventional Dose Followed by Low-Dose Apixaban for Venous Thromboembolism

  2023cites this paper
• Coagulation factors II, V, VII, IX, X and XI and mortality – a cohort study

  2023cites this paper
• Cost Effectiveness of Early Endovenous Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis in the United Kingdom.

  2023cites this paper
• The factors affecting the survivability of malignant cancer patients with deep vein thrombosis among subjects with gynecologic and non-gynecologic cancer: An ambispective cohort study

  2023influential citation
• To Study the Correlation of Clinical Severity and Cytokine Storm in COVID-19 Pulmonary Embolism Patients by Using Computed Tomography Pulmonary Angiography (CTPA) Qanadli Clot Burden Scoring System

  2023cites this paper
• Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study

  2023influential citation
• The Challenge of Intermediate-Risk Pulmonary Embolism

  2023cites this paper
• Economic Evaluation of Direct Oral Anticoagulants Compared to Warfarin for Venous Thromboembolism in Thailand: A Cost-Utility Analysis

  2023cites this paper
• Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study

  2023cites this paper
• Construction of Pulmonary Embolism Prediction, Early Warning, and Precontrol MDT Collaborative Nursing Model Based on the Smith Model

  2022cites this paper
• Prevalence of Venous Thromboembolism in Intensive Care Units: A Meta-Analysis

  2022cites this paper
• Editorial: Highlights in Thrombosis: 2021

  2022cites this paper
• Epidemiology and prevention of venous thromboembolism

  2022cites this paper
• The Higher Prevalence of Venous Thromboembolism in the Hungarian Roma Population Could Be Due to Elevated Genetic Risk and Stronger Gene-Environmental Interactions

  2021cites this paper
• Long-Term Survival After Venous Thromboembolism: A Prospective Cohort Study

  2021cites this paper
• Performance of pulmonary embolism severity index in predicting long-term mortality after acute pulmonary embolism.

  2021cites this paper
• Korean medicine treatment including oral administration of Gyejibongnyeong-hwan and acupuncture therapy for calf edema and pain due to deep vein thrombosis of lower leg: A Case Report

  2021cites this paper
• The Interaction Effect between Comorbidity Burden and Venous Thromboembolism on Mortality: A Nationwide Cohort Study

  2021cites this paper
• Glucocorticoid use and risk of first and recurrent venous thromboembolism: self‐controlled case‐series and cohort study

  2021cites this paper
• Mitochondria-DNA copy-number and incident venous thromboembolism among middle-aged women: a population-based cohort study

  2021cites this paper
• Restart TICrH: An Adaptive Randomized Trial of Time Intervals to Restart Direct Oral Anticoagulants after Traumatic Intracranial Hemorrhage

  2021cites this paper
• Pharmacologic Treatment of Pulmonary Embolism

  2021cites this paper
• Deep Vein Thrombosis in Intravenous Drug Users: An Invisible Global Health Burden

  2021cites this paper
• Concise Review of the Clinical Approach to the Exclusion and Diagnosis of Pulmonary Embolism in 2020.

  2020cites this paper
• The effects of the combination of angiotensin-converting enzyme inhibitor and diuretic on the lower limb venous circulation in men with hypertension and chronic venous disorders

  2020cites this paper
• Effect of the Combination of ACE Inhibitor and Calcium Channel Blockers on the Venous Circulatory Dynamics of Lower Limbs in Comorbid Arterial Hypertension and Chronic Vein Diseases

  2020cites this paper
• Optimizing the risk threshold of lymph node involvement for performing extended pelvic lymph node dissection in prostate cancer patients: a cost-effectiveness analysis.

  2020cites this paper
• Donor graft CMV-serostatus and the risk of arterial and venous thrombotic events in seronegative recipients after non-thoracic solid organ transplantation.

  2020cites this paper
• Preventing VTE following total hip and knee arthroplasty: Is prediction the future?

  2020cites this paper
• Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study

  2020cites this paper
• GENETIC FACTOR OF VENOUS THROMBOSIS IN TERMS OF INDIVIDUALIZED APPROACH TO TREATMENT OF PATIENTS WITH VENOUS THROMBOEMBOLIC COMPLICATIONS

  2020cites this paper
• Evaluating time to treatment and in-hospital outcomes of pulmonary embolism response teams.

  2020cites this paper
• Entscheidend bei Lungenembolie ist die hämodynamische Stabilität

  2019cites this paper
• Physical activity and risk of recurrence and mortality after incident venous thromboembolism

  2019cites this paper
• Long‐term outcomes in patients with pulmonary embolism: results from a longitudinal cohort study

  2019cites this paper
• Hyperhomocysteinaemia and the risk of recurrent venous thrombosis: results from the MEGA follow‐up study

  2019cites this paper
• Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk

  2019cites this paper
• Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)

  2019cites this paper
• Dietary Intake of Marine Polyunsaturated n-3 Fatty Acids and Risk of Recurrent Venous Thromboembolism

  2019cites this paper
• Self-rated health and venous thromboembolism among middle-aged women: a population-based cohort study

  2019cites this paper
• Chronic Obstructive Pulmonary Disease and Risk of Mortality in Patients with Venous Thromboembolism—The Tromsø Study

  2019cites this paper
• Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk

  2019cites this paper
• Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow‐up study

  2018cites this paper
• Association of Short-Term Mortality of Venous Thromboembolism with Family History of Venous Thromboembolism and Charlson Comorbidity Index

  2018cites this paper
• Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects

  2018cites this paper
• Diagnosis and Treatment Options for Pulmonary Embolism (PE) in the Acute Care Setting

  2018cites this paper
• Red cell distribution width and risk of venous thromboembolism

  2018influential citation
• Pulmonary embolism

  2018cites this paper
• Systemic Fibrinolytic Therapy in the Presence of Absolute Contraindication; a Case Series

  2018cites this paper
• Role of Routine Laboratory Tests in Assessing Risk of Recurrent Venous Thrombosis: Results from the MEGA Follow-Up Study

  2018cites this paper
• Short- and long-term mortality after pulmonary embolism in patients with and without cancer

  2018cites this paper
• Long‐Term Effects of Unprovoked Venous Thromboembolism on Mortality and Major Cardiovascular Events

  2017influential citation
• Lipid levels and risk of recurrent venous thrombosis: results from the MEGA follow‐up study

  2017cites this paper
• Design of a HIFU array for the treatment of deep venous thrombosis: a simulation study

  2017cites this paper
• Antibiotic use as a marker of acute infection and risk of first and recurrent venous thrombosis

  2017cites this paper
• Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands.

  2017cites this paper
• Direct Oral Anticoagulants and Vitamin K Antagonists for Treatment of Deep Venous Thrombosis and Pulmonary Embolism in the Outpatient Setting: Comparative Economic Evaluation.

  2017cites this paper
• Incidence of acute pulmonary embolism, related comorbidities and survival; analysis of a Swedish national cohort

  2017cites this paper
• Venous thromboembolism incidence, recurrence, and mortality based on Women's Health Initiative data and Medicare claims.

  2017cites this paper
• Recurrent venous thrombosis related to overweight and obesity: results from the MEGA follow‐up study

  2017cites this paper
• Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences

  2017cites this paper
• Endocrine-related factors and risk of venous thromboembolism

  2017cites this paper
• B idirectional association between arterial and venous thrombosis

  2017cites this paper
• of Venous Thromboembolism in the Framingham Heart Study Short title : VTE epidemiology in FHS

  2016cites this paper
• Cardiovascular disease and mortality after a first episode of venous thromboembolism in young and middle-aged women.

  2016cites this paper
• Coagulation factor levels in relation to venous thrombosis and cancer: Results from the MEGA study

  2016cites this paper
• Family history of venous thromboembolism and mortality after venous thromboembolism: a Swedish population-based cohort study

  2016cites this paper
• Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of Recurrence.

  2016cites this paper
• Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada

  2016cites this paper
• Hospital‐related first venous thromboembolism and risk of recurrence

  2016cites this paper
• Long-term consequences of venous thromboembolism in women

  2016cites this paper
• Epidemiology of venous thromboembolism in the Framingham Heart Study.

  2016cites this paper
• Coagulation disorders and their cutaneous presentations: Pathophysiology.

  2016cites this paper
• Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow‐up study

  2015cites this paper
• EXPLORATION OF NOVEL MECHANISMS AND BIOMARKERS FOR VENOUS THROMBOEMBOLISM - A GENETICS AND PROTEOMICS STUDY

  2015cites this paper
• Complications following hepatectomy.

  2015cites this paper
• Endovascular Management of Acute Pulmonary Embolism Using the Ultrasound-Enhanced EkoSonic System

  2015cites this paper
• Update in venous thromboembolism pathophysiology, diagnosis, and treatment for surgical patients.

  2015cites this paper
• Lack of association between Factor V Hong Kong and Venous thrombosis in the Chinese population.

  2015cites this paper
• How to predict short- and long-term mortality in patients with pulmonary embolism?

  2015cites this paper
• Venous thrombosis

  2015cites this paper
• Elevated levels of factor VIII and subsequent risk of all‐cause mortality: results from the MEGA follow‐up study

  2015cites this paper
• 30-Year Mortality After Venous Thromboembolism: A Population-Based Cohort Study

  2014influential citation
• Recurrent Venous Thromboembolism in a Patient with Heterozygous Factor V Leiden Mutation

  2014cites this paper
• Influence of coronary artery disease-associated genetic variants on risk of venous thromboembolism.

  2014cites this paper
• epidemiology ◼ mortality ◼ prognosis ◼ thromboembolism 30-Year Mortality After Venous Thromboembolism A Population-Based Cohort Study

  2014influential citation
• Deep Vein Thrombosis in Elderly Patients following Surgery for Fracture of the Proximal Femur.

  2014cites this paper